Filing Details

Accession Number:
0001179110-15-012883
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-02 16:51:34
Reporting Period:
2015-08-31
Filing Date:
2015-09-02
Accepted Time:
2015-09-02 16:51:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145460 Alere Inc. ALR In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1571630 Melissa Guerdan 51 Sawyer Road, Suite 200
Waltham MA 02453
Svp, Global Quality & Reg. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-31 8,333 $0.00 8,333 No 4 M Direct
Common Stock Disposition 2015-08-31 3,198 $51.97 5,135 No 4 F Direct
Common Stock Acquisiton 2015-09-01 5,000 $18.78 10,135 No 4 M Direct
Common Stock Disposition 2015-09-01 5,000 $50.48 5,135 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2015-08-31 8,333 $0.00 8,333 $0.00
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-09-01 5,000 $0.00 5,000 $18.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,667 No 4 M Direct
4,555 2022-08-31 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of Alere common stock.
  2. On August 31, 2014, the reporting person was granted 25,000 restricted stock units, which vest as follows: 8,333 on the first anniversary of the grant date (8/31/15); 8,333 on the second anniversary of the grant date (8/31/16); and 8,334 on the third anniversary of the grant date (8/31/17).
  3. The transactions reported on this Form were made pursuant to a written 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents same day exercise and sale of stock options.
  4. Option will vest in four equal installments on 8/31/13, 8/31/14, 8/31/15 and 8/31/16.
  5. This derivative security does not have a price.